MSA
PRAH

Mason Street Advisors’s PRA Health Sciences, Inc. PRAH Stock Holding History

Mason Street Advisors’s Portfolio PRAH Stock Details PRAH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-34,261
Closed -$4.3M – 1430
2020
Q4 		$4.3M Buy
34,261
+28
+0.1% +$3.13K 0.07% 275
2020
Q3 		$3.47M Sell
34,233
-634
-2% -$64.6K 0.07% 297
2020
Q2 		$3.39M Buy
34,867
+1,226
+4% +$114K 0.07% 284
2020
Q1 		$2.79M Hold
33,641
– – 0.06% 298
2019
Q4 		$3.74M Buy
33,641
+710
+2% +$73K 0.07% 298
2019
Q3 		$3.27M Buy
32,931
+1,431
+5% +$142K 0.07% 325
2019
Q2 		$3.12M Buy
31,500
+137
+0.4% +$13.1K 0.07% 341
2019
Q1 		$3.46M Buy
31,363
+732
+2% +$76.5K 0.07% 302
2018
Q4 		$2.82M Buy
30,631
+876
+3% +$88.6K 0.07% 313
2018
Q3 		$3.28M Buy
29,755
+3,793
+15% +$395K 0.07% 307
2018
Q2 		$2.42M Buy
+25,962
New +$2.24M 0.05% 442

Other funds holding PRAH

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return
AAM
Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return

Mason Street Advisors's PRAH Position: Q1 2021 in Review

Mason Street Advisors sold out of PRA Health Sciences, Inc. (PRAH) in Q1 2021, closing a stake of 34,261 shares — an estimated $4.3M sold.

Mason Street Advisors first reported a position in PRAH in Q2 2018 and held it in 11 quarters. The position peaked at $4.3M in Q4 2020. 324 funds tracked by Wall St. Rank hold PRAH as of Q1 2021.

  • Mason Street Advisors reported no remaining PRA Health Sciences, Inc. position as of Q1 2021 after selling out during the quarter.
  • Mason Street Advisors sold 34,261 PRA Health Sciences, Inc. shares in Q1 2021, an estimated $4.3M.
  • Mason Street Advisors first reported a position in PRA Health Sciences, Inc. in Q2 2018 and held it in 11 quarters.
  • Mason Street Advisors's PRA Health Sciences, Inc. position peaked at $4.3M in Q4 2020.
  • 324 funds tracked by Wall St. Rank held PRA Health Sciences, Inc. as of Q1 2021.

Based on Mason Street Advisors's 13F filing for Q1 2021, filed 14 May 2021.